We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Scientists Work Towards a CRISPR-based COVID-19 Therapy

News   Jun 04, 2020 | Original story from the Berkeley Lab

 
Scientists Work Towards a CRISPR-based COVID-19 Therapy

Lipitoids, which self-assemble with DNA and RNA, could serve as cellular delivery systems for antiviral therapies that prevent COVID-19 and other coronavirus infections. Credit: R.N. Zuckermann.

 
 
Advertisement
 

RELATED ARTICLES

“Common Cold” Coronaviruses Could Help Produce Anti-SARS-CoV-2 Immune Cells

News

Researchers examining immune cells produced against coronaviruses have uncovered a wealth of information about how this critical aspect of immunity could fight off COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. The new study provides hope that some immune responses to SARS-CoV-2 could be long-lasting.

READ MORE

How Much Fluorine Is Too Much?

News

A new study has explored whether soil fluorine levels in New Zealand are high enough to hurt a Rhizobium, bacteria that support legume crops.

READ MORE

Could Heparin Be Used To Stop SARS-CoV-2 From Infecting Human Cells?

News

SARS-CoV-2 uses a surface spike protein to latch onto human cells and initiate infection. But, the drug heparin is capable of binding tightly to the same surface spike protein, potentially blocking the infection from happening.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE